NCT03018366
|
Cedars-Sinai Medical Center
|
Estrogen Deficiency|Cardiovascular Disease (CVD)|Hypothalamic Amenorrhea
|
January 2017
|
Phase 2
|
NCT00338052
|
Warner Chilcott
|
Contraception
|
June 2006
|
Phase 2
|
NCT00722800
|
Massachusetts General Hospital|Bayer
|
Hidradenitis Suppurativa
|
October 2008
|
Phase 2
|
NCT00554632
|
University of Vermont|University of Vermont Medical Center
|
Venous Thrombosis
|
April 2003
|
Not Applicable
|
NCT00640224
|
Silva Arslanian|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|University of Pittsburgh
|
Polycystic Ovary Syndrome
|
March 2005
|
Phase 4
|
NCT00909857
|
Bayer
|
Primary Dysmenorrhea
|
April 2009
|
Phase 3
|
NCT02330757
|
Mansoura University
|
Infertility
|
January 2015
|
Phase 4
|
NCT01076621
|
Novo Nordisk A+S
|
Menopause|Postmenopausal Bleeding
|
May 2010
|
|
NCT02255396
|
University Hospital, Clermont-Ferrand
|
Non-obstructive Azoospermia With Testicular Biopsy for Spermatozoa Extraction
|
January 2009
|
|
NCT00361075
|
Northwestern University|University of Washington
|
Menopause|Postmenopause|Premenopause|Cardiovascular Disease
|
July 1998
|
Phase 4
|
NCT01597986
|
Astellas Pharma Global Development, Inc.|Basilea Pharmaceutica International Ltd|Astellas Pharma Inc
|
Pharmacokinetics of Isavuconazole|Pharmacokinetics of Ethinyl Estradiol and Norethindrone|Healthy Volunteers
|
April 2012
|
Phase 1
|
NCT02272647
|
Mayo Clinic
|
Healthy
|
December 2014
|
Phase 1
|
NCT00999479
|
University of Oklahoma
|
Endometrioma
|
October 2009
|
Not Applicable
|
NCT01448291
|
Eastern Virginia Medical School|Merck Sharp & Dohme Corp.
|
Vaginosis, Bacterial
|
October 2011
|
Phase 4
|
NCT03332303
|
Prasco LLC
|
Vulvar and Vaginal Atrophy
|
October 18, 2017
|
Phase 3
|
NCT02638922
|
Rigshospitalet, Denmark
|
Constitutional Tall Stature
|
January 2014
|
|
NCT03329898
|
Beijing Obstetrics and Gynecology Hospital
|
Intrauterine Adhesion
|
October 31, 2017
|
Not Applicable
|
NCT01209143
|
Genentech, Inc.
|
Solid Cancers
|
November 2010
|
Phase 1
|
NCT02210702
|
The Jones Institute
|
Postpartum Depressive Mood|Postpartum Sexual Function
|
July 2014
|
Phase 4
|
NCT01023178
|
Stanford University
|
Ovarian Failure, Premature
|
February 2007
|
Not Applicable
|
NCT00307632
|
Janssen-Cilag Farmaceutica Ltda.
|
Contraception
|
February 2003
|
Phase 4
|
NCT01083641
|
University of Wisconsin, Madison
|
Female Breast Cancer
|
January 2010
|
Phase 2
|
NCT01569945
|
University Hospital, Gasthuisberg
|
Subfertility
|
September 2004
|
Not Applicable
|
NCT01928082
|
University of Chicago
|
Hypercalciuria|Hypercalciuria, Familial Idiopathic|Osteopenia|Osteoporosis
|
August 1, 2013
|
Phase 2
|
NCT01301183
|
Massachusetts General Hospital
|
Anorexia Nervosa
|
February 2011
|
Phase 3
|
NCT02161614
|
Federal University of Minas Gerais|Fundação de Amparo à Pesquisa do estado de Minas Gerais
|
Flow-mediated Dilation Evaluation of the Brachial Artery
|
February 2014
|
Not Applicable
|
NCT01845649
|
Warner Chilcott
|
Vulvovaginal Atrophy
|
April 2013
|
Phase 3
|
NCT00066157
|
University of Wisconsin, Madison|National Institute on Aging (NIA)
|
Alzheimer Disease
|
September 2001
|
Phase 2|Phase 3
|
NCT00302731
|
Jeanne Drisko, MD, CNS, FACN|Private Foundation through KU Endowment|University of Kansas|University of Kansas Medical Center
|
Menopause
|
February 2006
|
Phase 2
|
NCT02238808
|
AHS Cancer Control Alberta
|
Estrogen Receptor Positive Breast Cancer
|
August 2015
|
Phase 2
|
NCT01165307
|
Abimbola Famuyide|Hologic, Inc.|Mayo Clinic
|
Menorrhagia
|
August 2009
|
Phase 4
|
NCT01553773
|
Federal University of São Paulo|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
|
Atrophy
|
July 2004
|
Phase 2
|
NCT02744131
|
Kar Clinic & Hospital Pvt. Ltd.|All India Institute of Medical Sciences, New Delhi|Nova IVI Fertility, New Delhi|Dr Patil´s Fertility & Endoscopy Clinic, Bangalore|Shreyas Hospital & Sushrut Assisted Conception Clinic, Kolhapur|University of Messina
|
Polycystic Ovary Syndrome
|
May 2016
|
Not Applicable
|
NCT02114645
|
Zekai Tahir Burak Women´s Health Research and Education Hospital
|
Infertility
|
April 2014
|
Not Applicable
|
NCT01087879
|
University of Oulu
|
Contraception
|
October 2007
|
Not Applicable
|
NCT02255175
|
University of North Carolina, Chapel Hill|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute of Mental Health (NIMH)
|
Perimenopausal Depression
|
October 1, 2015
|
Phase 4
|
NCT00191113
|
Eli Lilly and Company
|
Turner Syndrome
|
February 1989
|
Phase 3
|
NCT01780558
|
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
|
Infertility
|
January 2010
|
Not Applicable
|
NCT03789123
|
Bagcilar Training and Research Hospital|Kocaeli Derince Education and Research Hospital|Suleymaniye Birth And Women´s Health Education And Research Hospital
|
Ovarian Reserve
|
January 1, 2019
|
Phase 4
|
NCT01385280
|
University of Arizona|National Cancer Institute (NCI)
|
Estrogen Receptor-positive Breast Cancer|Progesterone Receptor Positive Tumor|Recurrent Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
|
February 2011
|
Not Applicable
|
NCT03240081
|
Oregon Health and Science University
|
Dyspareunia
|
June 20, 2017
|
Phase 4
|
NCT01250210
|
Agile Therapeutics
|
Ovulation Suppression
|
September 2007
|
Phase 2
|
NCT00608062
|
University of Colorado, Denver|National Institute on Aging (NIA)
|
Arterial Stiffening|Aging|Menopause
|
March 2007
|
Not Applicable
|
NCT00455156
|
Health Decisions|Population Council|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Contraception
|
December 2006
|
Phase 3
|
NCT03720847
|
University of North Carolina, Chapel Hill|National Institute of Mental Health (NIMH)
|
Suicidal Ideation
|
December 31, 2016
|
Phase 4
|
NCT02677259
|
One Fertility
|
IVF
|
May 2016
|
Phase 2
|
NCT03371654
|
University of Illinois at Chicago|National Institute of Mental Health (NIMH)
|
Stress Disorders, Post-Traumatic|Healthy
|
November 29, 2017
|
Phase 4
|
NCT01297348
|
Pfizer|Boston Collaborative Drug Surveillance Program
|
Venous Thrombosis|Pulmonary Embolism|Sinus Thrombosis, Intracranial
|
July 2007
|
|
NCT03043924
|
University Hospital, Lille|National Research Agency, France
|
Polycystic Ovary Syndrome
|
September 26, 2017
|
Not Applicable
|
NCT01432028
|
Denusa Wiltgen|Hospital de Clinicas de Porto Alegre|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Federal University of Rio Grande do Sul
|
Postmenopause
|
March 2007
|
Not Applicable
|
NCT01943812
|
Peter Humaidan|Regionshospitalet Viborg, Skive
|
Pregnancy Loss|Frozen Embryo Transfer
|
December 2013
|
Phase 4
|
NCT02349386
|
BHR Pharma, LLC|H2O Clinical LLC|Q2 Solutions
|
Cancer of the Prostate
|
July 2015
|
Phase 2
|
NCT00160173
|
ASCEND Therapeutics|Solvay Pharmaceuticals
|
Postmenopausal Symptoms
|
|
Phase 4
|
NCT01040845
|
Mutual Pharmaceutical Company, Inc.
|
Pharmacokinetics
|
August 2007
|
Phase 1
|
NCT00465894
|
University of Alabama at Birmingham|Pfizer
|
Overactive Bladder
|
April 2007
|
Not Applicable
|
NCT01850095
|
Marco Alexandre Dias da Rocha|Fleury|Associacao Fundo de Incentivo a Psicofarmcologia|Bayer|Federal University of São Paulo
|
Acne|Quality of Life
|
March 2012
|
Not Applicable
|
NCT00206570
|
Bayside Health|National Alliance for Research on Schizophrenia and Depression|Stanley Medical Research Institute|National Health and Medical Research Council, Australia
|
Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder
|
January 2001
|
Phase 2
|
NCT00176644
|
University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI)|Rutgers, The State University of New Jersey
|
Prostate Cancer
|
May 2005
|
Phase 2
|
NCT00511355
|
Merck Sharp & Dohme Corp.
|
Contraception
|
October 2006
|
Phase 3
|
NCT01103518
|
Fundação Educacional Serra dos Órgãos
|
Amenorrhea|Dysmenorrhea|Menstruation Disturbances|Hyperandrogenism
|
December 2009
|
Phase 4
|
NCT02673606
|
Massachusetts General Hospital
|
Healthy Naturally Cycling Women
|
|
|
NCT00905723
|
Federal University of São Paulo
|
Postmenopausal Symptoms
|
May 2009
|
Phase 3
|
NCT00195559
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Premenstrual Syndrome|Menstruation Disturbances
|
September 2005
|
Phase 3
|
NCT03620929
|
Fu Xing Hospital, Capital Medical University
|
Asherman Syndrome
|
August 13, 2018
|
Phase 4
|
NCT00789802
|
Washington University School of Medicine|American College of Obstetricians and Gynecologists
|
Contraception|Bleeding
|
November 2008
|
Not Applicable
|
NCT00653016
|
Janssen-Ortho Inc., Canada
|
Female Contraception
|
October 2002
|
Phase 4
|
NCT01923298
|
University of Arizona
|
Estrogen Levels Among Breast Cancer Patients
|
August 9, 2013
|
Phase 2
|
NCT02127593
|
Janssen Research & Development, LLC
|
Healthy
|
June 2013
|
Phase 1
|
NCT01218386
|
Universitair Ziekenhuis Brussel
|
Infertility
|
May 2010
|
Phase 4
|
NCT02872818
|
Kayseri Education and Research Hospital
|
Apoptotic Signal Pathways in Endometrial Hyperplasia
|
October 2014
|
Phase 4
|
NCT02496052
|
Beijing Obstetrics and Gynecology Hospital
|
Intrauterine Adhesions
|
January 2013
|
Not Applicable
|
NCT01668446
|
farzaneh hojjat|Razieh dehghani firouzabadi|Robab davar|Shahid Sadoughi University of Medical Sciences and Health Services
|
Endometrial Preparation|Frozen Embryo Transfer
|
September 2009
|
Phase 4
|
NCT01909141
|
Cairo University
|
Polycystic Ovary Syndrome|Infertility
|
August 2013
|
Early Phase 1
|
NCT01182207
|
Teva Pharmaceuticals USA
|
Healthy
|
July 2006
|
Phase 1
|
NCT00477633
|
Warner Chilcott
|
Contraception
|
June 2007
|
Phase 3
|
NCT03608241
|
Pfizer
|
Healthy Females
|
September 21, 2018
|
Phase 1
|
NCT01182194
|
Teva Pharmaceuticals USA
|
Healthy
|
June 2006
|
Phase 1
|
NCT03642665
|
Universitaire Ziekenhuizen Leuven|GZA Ziekenhuizen Campus Sint-Augustinus|Imelda Hospital, Bonheiden|Jessa Hospital
|
Embryo Transfer
|
September 1, 2018
|
Phase 4
|
NCT00455962
|
Massachusetts General Hospital|National Institutes of Health (NIH)|National Institute on Aging (NIA)
|
Premenopause|Healthy
|
January 2005
|
Phase 1|Phase 2
|
NCT00294463
|
Erasmus Medical Center|Organon
|
Postmenopause|Osteoporosis
|
February 2003
|
Phase 4
|
NCT02531321
|
University of Southern California
|
Contraception|HIV
|
August 2015
|
Phase 4
|
NCT00775086
|
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
|
Female Contraception
|
May 2004
|
Phase 1
|
NCT01613131
|
University of Colorado, Denver|Bayer
|
Menopausal and Other Perimenopausal Disorders
|
April 2012
|
Not Applicable
|
NCT02475265
|
Massachusetts General Hospital|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
Anorexia Nervosa|Osteoporosis
|
July 2015
|
Phase 2
|
NCT00837616
|
Nemours Children´s Clinic|Genentech, Inc.
|
Turner Syndrome|Hypogonadism|Premature Ovarian Failure
|
January 2009
|
Phase 4
|
NCT01709318
|
Merck Sharp & Dohme Corp.
|
Contraception
|
December 2012
|
Phase 2
|
NCT02406690
|
Reproductive Medicine Associates of New Jersey
|
Endometrial Dysfunction
|
July 31, 2015
|
|
NCT00754065
|
Bayer
|
Contraception
|
September 2008
|
Phase 3
|
NCT03724955
|
Emory University
|
Cystic Fibrosis Related Bone Disease
|
December 2018
|
Phase 4
|
NCT00005108
|
National Heart, Lung, and Blood Institute (NHLBI)|National Institutes of Health Clinical Center (CC)
|
Atherosclerosis|Healthy|Vascular Disease
|
April 2000
|
Phase 2
|
NCT00251082
|
Solvay Pharmaceuticals
|
Postmenopause
|
December 2005
|
Phase 3
|
NCT03120728
|
University of Southern California
|
Emergency Contraception|Healthy, Reproductive Age Women
|
July 10, 2017
|
Phase 4
|
NCT02668796
|
Glenmark Pharmaceuticals Ltd. India
|
Vulvar and Vaginal Atrophy
|
January 2016
|
Phase 3
|
NCT03351205
|
Beijing Obstetrics and Gynecology Hospital
|
Intrauterine Adhesion
|
November 21, 2017
|
Not Applicable
|
NCT01501448
|
IVI Madrid
|
Infertility
|
January 2012
|
Phase 4
|
NCT00816556
|
Maire Mac Bride|National Center for Advancing Translational Science (NCATS)|Mayo Clinic
|
Atrophic Vaginitis
|
October 2008
|
Phase 3
|
NCT01698164
|
Peking Union Medical College Hospital
|
Menopausal Syndrome|Cardiovascular Disease|Osteoporosis|Breast Cancer
|
December 2008
|
Phase 4
|
NCT02218463
|
Children´s Mercy Hospital Kansas City|University of Missouri, Kansas City
|
Prepubertal Labial Adhesions
|
September 2014
|
Not Applicable
|
NCT03531437
|
Mahidol University
|
Contraception|Hypercoagulability
|
March 2016
|
Phase 4
|
NCT03749733
|
Grünenthal GmbH|Grünenthal Colombiana S.A.
|
Bioequivalence
|
February 2019
|
Phase 1
|
NCT01942668
|
TherapeuticsMD
|
Menopause
|
August 5, 2013
|
Phase 3
|
NCT01511822
|
AGUNCO Obstetrics and Gynecology Centre
|
PCOS|Polycystic Ovary Syndrome
|
|
Phase 4
|
NCT03662516
|
Pfizer
|
Healthy Females
|
September 26, 2018
|
Phase 1
|
NCT01659008
|
Kay I Waud MD PhD|American College of Obstetricians and Gynecologists|Eastern Virginia Medical School
|
Menstrual Cycle and Uterine Bleeding Disorders
|
June 2012
|
Not Applicable
|
NCT02872818
|
Kayseri Education and Research Hospital
|
Apoptotic Signal Pathways in Endometrial Hyperplasia
|
October 2014
|
Phase 4
|
NCT03346317
|
Beijing Obstetrics and Gynecology Hospital
|
Intrauterine Adhesion
|
November 16, 2017
|
Not Applicable
|
NCT00044837
|
National Institute of Allergy and Infectious Diseases (NIAID)
|
HIV Infections
|
|
Phase 1
|
NCT02846142
|
Proteostasis Therapeutics, Inc.
|
Healthy Volunteer
|
June 2016
|
Phase 1
|
NCT00662454
|
Oregon Health and Science University|National Institutes of Health (NIH)|Oregon Clinical and Translational Research Institute
|
Contraception|Body Weight
|
January 2006
|
Phase 4
|
NCT01705249
|
Novo Nordisk A+S
|
Menopause|Healthy
|
August 14, 2001
|
Phase 4
|
NCT01310647
|
Instituto de Investigacion Sanitaria La Fe
|
Ovarian Diseases
|
June 2011
|
Phase 2
|
NCT01780610
|
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
|
Infertility
|
January 2012
|
Not Applicable
|
NCT00080756
|
City of Hope Medical Center|National Cancer Institute (NCI)
|
brca1 Mutation Carrier|brca2 Mutation Carrier|Breast Cancer
|
March 11, 2004
|
Phase 2
|
NCT02847806
|
University Hospital, Caen
|
Hypogonadism
|
January 2008
|
Phase 3
|
NCT02186782
|
Maher elesawi kamel elesawi|Mansoura University
|
Infertility|Anovulation
|
June 2014
|
Phase 4
|
NCT00154180
|
Kronos Longevity Research Institute|Albert Einstein College of Medicine, Inc.|Brigham and Women´s Hospital|Columbia University|Mayo Clinic|University of California, San Francisco|University of Utah|University of Washington|Yale University
|
Menopause|Arteriosclerosis
|
September 2005
|
Phase 4
|
NCT00732693
|
University of Edinburgh
|
Premature Ovarian Failure
|
February 2002
|
Phase 4
|
NCT00740194
|
University Hospital, Ghent
|
Healthy
|
August 2008
|
Phase 1|Phase 2
|
NCT00236769
|
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
|
Contraception|Female Contraception
|
November 1997
|
Phase 3
|
NCT00722761
|
Massachusetts General Hospital|Bayer
|
Acne Vulgaris
|
April 2009
|
Phase 3
|
NCT00161681
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Premenstrual Syndrome
|
July 2005
|
Phase 3
|
NCT00030147
|
National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC)
|
Perimenopausal Depression|Depression
|
February 2002
|
Phase 4
|
NCT03336437
|
Oregon Health and Science University
|
Menopause
|
February 1, 2018
|
Phase 4
|
NCT00293059
|
Bayer
|
Metrorrhagia
|
December 2005
|
Phase 3
|
NCT00744328
|
Northwestern University
|
Postpartum Depression
|
August 2008
|
Phase 4
|
NCT03294538
|
Actavis Inc.
|
Atrophic Vaginitis
|
May 18, 2016
|
Phase 3
|
NCT02449902
|
TherapeuticsMD
|
Menopause|Vulvovaginal Atrophy|Painful Intercourse|Dyspareunia
|
July 2013
|
Phase 2
|
NCT01388491
|
Teva Branded Pharmaceutical Products, R&D Inc.|Teva Pharmaceutical Industries
|
Hemostasis|Oral Contraceptive
|
October 2011
|
Phase 2
|
NCT01605071
|
University of Colorado, Denver|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
Insulin Resistance
|
September 2011
|
Not Applicable
|
NCT02859285
|
ProHealth Care, Inc
|
Hypoactive Sexual Desire Disorder
|
April 2016
|
Not Applicable
|
NCT01986764
|
University of Pennsylvania
|
Planned RRSO
|
July 1, 2013
|
Not Applicable
|
NCT03249402
|
Janssen-Cilag International NV
|
Healthy
|
August 14, 2017
|
Phase 1
|
NCT01046643
|
University of Michigan|National Institute on Aging (NIA)
|
Menopausal Syndrome
|
May 2010
|
Not Applicable
|
NCT01779947
|
Amneal Pharmaceuticals, LLC
|
Atrophic Vaginitis Due to Menopause
|
March 2012
|
Phase 3
|
NCT00324259
|
Washington University School of Medicine
|
Breast Neoplasms
|
August 2004
|
Phase 2
|
NCT03124524
|
Adana Numune Training and Research Hospital
|
Primary Dysmenorrhea
|
January 15, 2015
|
Phase 4
|
NCT03060304
|
Sun Yat-sen University
|
Endometrium
|
March 2017
|
Phase 4
|
NCT03155048
|
Memorial Sisli Hospital, Istanbul
|
Infertility
|
May 1, 2017
|
Not Applicable
|
NCT00117273
|
Duramed Research|Teva Pharmaceutical Industries
|
Healthy
|
June 2005
|
Phase 3
|
NCT02021097
|
Regenex Pharmaceutical, China
|
Oral Contraceptive
|
February 2012
|
Phase 3
|
NCT01419353
|
Meir Medical Center
|
Infertility
|
August 2011
|
Phase 4
|
NCT00026962
|
National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
|
Breast Cancer
|
September 1999
|
Phase 2
|
NCT02103569
|
Bristol-Myers Squibb
|
Hepatitis C
|
April 2014
|
Phase 1
|
NCT01723579
|
Merck Sharp & Dohme Corp.
|
Contraception
|
July 2013
|
Phase 3
|
NCT00391417
|
BioSante Pharmaceuticals
|
Hot Flashes
|
September 2003
|
Phase 3
|
NCT03518528
|
University Hospital, Angers
|
Embryo Transfer|Infertility
|
August 30, 2018
|
|
NCT00447863
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Contraception
|
August 2007
|
Phase 1
|
NCT00435175
|
University of Aarhus
|
Postmenopause
|
June 2005
|
Not Applicable
|
NCT02253173
|
TherapeuticsMD
|
Vulvovaginal Atrophy|Menopause|Dyspareunia|Painful Intercourse
|
September 2014
|
Phase 3
|
NCT03779633
|
Medical University of Vienna
|
Pelvic Organ Prolapse
|
February 2, 2017
|
Phase 4
|
NCT00127075
|
Hospices Civils de Lyon
|
Multiple Sclerosis
|
June 2005
|
Phase 3
|
NCT00612508
|
Oregon Health and Science University|Oregon Clinical and Translational Research Institute
|
Contraceptive Usage|Vaginal Epithelial Disruption
|
May 2007
|
Not Applicable
|
NCT00059228
|
National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC)
|
Postpartum Depression|Depression
|
April 17, 2003
|
Phase 2
|
NCT03069781
|
McMaster University
|
Muscle Atrophy
|
May 2017
|
Early Phase 1
|
NCT00547001
|
Hartford Hospital
|
Hot Flashes|Night Sweats
|
August 2007
|
Not Applicable
|
NCT01126801
|
Massachusetts General Hospital|National Institutes of Health (NIH)
|
Menopausal Depression
|
May 2010
|
Phase 2
|
NCT01546454
|
Oregon Health and Science University|Medical Research Foundation, Oregon
|
Coronary Heart Disease
|
February 2012
|
Not Applicable
|
NCT01268046
|
Massachusetts General Hospital|National Institute on Aging (NIA)
|
Memory Loss|Cognitive Changes|Postmenopausal Symptoms
|
November 2009
|
Phase 1|Phase 2
|
NCT01153581
|
Yale University|National Heart, Lung, and Blood Institute (NHLBI)
|
Orthostatic Intolerance
|
February 2006
|
Phase 2
|
NCT00755963
|
Medical University of Vienna
|
Hormone Replacement
|
May 2009
|
Phase 4
|
NCT00357006
|
The Alfred|Stanley Medical Research Institute
|
Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder(Not in Manic Phase)
|
July 2006
|
Phase 2
|
NCT02668783
|
Merck Sharp & Dohme Corp.
|
Moderate to Severe Primary Dysmenorrhea
|
February 11, 2016
|
Phase 3
|
NCT00303784
|
Imperial College London|Medical Research Council|University College, London
|
Anemia|Cardiovascular Complications|Hot Flashes|Osteoporosis|Prostate Cancer
|
March 2006
|
Phase 3
|
NCT00472004
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Vasomotor Symptoms
|
February 2006
|
Phase 4
|
NCT02245438
|
Boehringer Ingelheim
|
Healthy
|
May 2002
|
Phase 1
|
NCT03788681
|
Ain Shams University
|
ICSI
|
April 1, 2018
|
Phase 3
|
NCT00649896
|
Mylan Pharmaceuticals
|
Healthy
|
August 2003
|
Phase 1
|
NCT00000559
|
National Heart, Lung, and Blood Institute (NHLBI)
|
Cardiovascular Diseases|Coronary Disease|Heart Diseases|Myocardial Ischemia|Postmenopause
|
March 1995
|
Phase 3
|
NCT00042289
|
National Institute of Allergy and Infectious Diseases (NIAID)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
HIV Infections
|
March 2003
|
Phase 4
|
NCT01087593
|
Ostergotland County Council, Sweden
|
Fibromyalgia
|
August 2001
|
Not Applicable
|
NCT01389102
|
Lumara Health, Inc.
|
Hot Flashes
|
December 2004
|
Phase 3
|
NCT01344369
|
Teva Pharmaceuticals USA
|
Healthy
|
August 2008
|
Phase 1
|
NCT01056042
|
Prince of Songkla University
|
Endometriosis
|
June 2007
|
Phase 4
|
NCT01200537
|
Duke University|Emory University
|
IVF Poor Responders
|
October 2010
|
Not Applicable
|
NCT01353846
|
Instituto Valenciano de Infertilidad, IVI VALENCIA
|
Infertility
|
May 2011
|
Phase 4
|
NCT03236545
|
University of Delaware|American Heart Association
|
Cardiovascular Risk Factor
|
July 1, 2016
|
Not Applicable
|
NCT01790282
|
Mansoura Integrated Fertility Center
|
IVF|Infertility
|
March 2013
|
Not Applicable
|
NCT02224313
|
Intira Sriprasert|TherapeuticsMD|Eastern Virginia Medical School
|
Menopause
|
December 2015
|
Not Applicable
|
NCT00446199
|
Bayer
|
Vasomotor Symptoms|Hot Flashes
|
March 2007
|
Phase 3
|
NCT03074045
|
Bayer
|
Contraception
|
March 13, 2017
|
Phase 3
|
NCT01633814
|
University of Missouri-Columbia
|
Menopause|Aging|Blood Pressure
|
September 2011
|
Not Applicable
|
NCT02273791
|
Mansoura University
|
Infertility|Polycystic Ovarian Syndrome
|
December 2013
|
|
NCT00195455
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Postmenopause
|
February 2005
|
Phase 4
|
NCT01822288
|
Far Eastern Memorial Hospital
|
Menopausal Syndromes
|
December 2012
|
Phase 4
|
NCT01810315
|
CONRAD
|
HIV Prevention
|
September 2013
|
Phase 1
|
NCT01753102
|
Sun Pharmaceutical Industries Limited
|
Vulvar Atrophy|Vaginal Atrophy
|
November 6, 2012
|
Phase 3
|
NCT00320567
|
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
|
Osteoporosis
|
|
Phase 2
|
NCT03324685
|
Biogen
|
Drug Interactions
|
November 11, 2017
|
Phase 1
|
NCT00254800
|
AstraZeneca|Eli Lilly and Company
|
Type 2 Diabetes Mellitus
|
November 2005
|
Phase 1
|
NCT02485821
|
Ain Shams University
|
Failed Induction of Labor
|
June 2015
|
Phase 2|Phase 3
|
NCT00633360
|
Massachusetts General Hospital|Bayer
|
Premenstrual Syndrome|Depression
|
February 2008
|
Not Applicable
|
NCT03740204
|
Massachusetts General Hospital
|
Eating Disorders|Hypoestrogenemia
|
April 1, 2019
|
Phase 2
|
NCT03301233
|
Ain Shams University
|
Endometrial Thickness
|
November 1, 2017
|
Not Applicable
|
NCT00033358
|
National Cancer Institute (NCI)
|
Endometrial Cancer
|
February 2002
|
Phase 2
|
NCT01293747
|
Productos Científicos S. A. de C. V.
|
Menopause
|
February 2011
|
Phase 1
|
NCT00829114
|
FHI 360|United States Agency for International Development (USAID)|Makerere University|RHRU National Office, University of Witwatersand, Johannesburg
|
HIV+AIDS|HIV Infections
|
March 2009
|
Phase 4
|
NCT00459810
|
OHSU Knight Cancer Institute|National Cancer Institute (NCI)
|
Prostate Cancer
|
February 2007
|
Phase 2
|
NCT00687739
|
University of Colorado, Denver|National Institute on Aging (NIA)
|
Obesity
|
May 2008
|
Phase 3
|
NCT00319163
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Healthy
|
May 2006
|
Phase 1
|
NCT03300518
|
Reproductive & Genetic Hospital of CITIC-Xiangya|Merck Sharp & Dohme Corp.
|
Infertility
|
November 15, 2017
|
Not Applicable
|
NCT02792153
|
Johns Hopkins University
|
Anorexia Nervosa
|
December 2016
|
Phase 1
|
NCT00332553
|
Eli Lilly and Company
|
Vasomotor Symptoms|Endometrial Safety
|
February 2002
|
Phase 2
|
NCT00685906
|
AstraZeneca
|
Healthy
|
April 2008
|
Phase 1
|
NCT00344383
|
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
|
Metrorrhagia
|
November 2003
|
Phase 2
|
NCT00261482
|
Janssen Pharmaceutica N.V., Belgium
|
Contraception|Female Contraception
|
July 2003
|
Phase 4
|
NCT00307801
|
Bayer
|
Metrorrhagia
|
February 2006
|
Phase 3
|
NCT03385551
|
Instituto Palacios
|
Vulvovaginal Atrophy
|
December 2, 2018
|
|
NCT00212277
|
Nobelpharma
|
Dysmenorrhea
|
February 2005
|
Phase 3
|
NCT00860964
|
Peking Union Medical College
|
Osteoporosis
|
February 1998
|
Phase 4
|
NCT03479879
|
Ain Shams University
|
Miscarriage
|
March 21, 2018
|
Phase 2|Phase 3
|
NCT03033160
|
Boston Urogynecology Associates|Beth Israel Deaconess Medical Center|Mount Auburn Hospital
|
Asymptomatic Microscopic Hematuria
|
December 2016
|
Phase 4
|
NCT03493126
|
Pamela Smith|Ohio State University
|
Vaginal Atrophy
|
October 15, 2018
|
Phase 4
|
NCT00134745
|
Line Cleemann|Novo Nordisk A+S|The County of Frederiksborg|The foundation of Kaptajnløjtnant Harald Jensen and Wife|The foundation of Mrs. Olga Bryde|The foundation of Mr. Ivan Nielsen|Hillerod Hospital, Denmark
|
Turner Syndrome
|
June 2005
|
Phase 4
|
NCT01070979
|
Warner Chilcott
|
Hormone Replacement Therapy
|
February 2003
|
Phase 3
|
NCT01120665
|
University of Sao Paulo General Hospital|Fundação de Amparo à Pesquisa do Estado de São Paulo
|
Women´s Health
|
February 2002
|
Not Applicable
|
NCT02533427
|
Gilead Sciences
|
HCV Infection
|
October 2015
|
Phase 1
|
NCT00650442
|
Mylan Pharmaceuticals
|
Healthy
|
January 2003
|
Phase 1
|
NCT01455597
|
Warner Chilcott
|
Vulvovaginal Atrophy
|
October 2011
|
Phase 3
|
NCT00426972
|
Renovo
|
Burn|Trauma|Varicose Ulcer
|
January 2007
|
Phase 3
|
NCT00357604
|
Bristol-Myers Squibb
|
HIV Infections
|
July 2006
|
Phase 1
|
NCT01221831
|
Estetra
|
Contraception
|
September 2010
|
Phase 2
|
NCT00006133
|
National Center for Research Resources (NCRR)|University of Alabama at Birmingham
|
Systemic Lupus Erythematosus
|
June 2000
|
Not Applicable
|
NCT01065220
|
Medical University of Vienna
|
Transsexualism
|
February 2010
|
Phase 4
|
NCT00248963
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Oral Contraceptive
|
|
Phase 3
|
NCT02715232
|
Medical University of Vienna
|
Gender Dysphoria
|
February 6, 2017
|
Phase 4
|
NCT00471991
|
Bayer
|
Oral Contraceptive
|
April 2007
|
Phase 2
|
NCT01291004
|
Teva Branded Pharmaceutical Products, R&D Inc.|Teva Pharmaceutical Industries
|
Follicle Development|Ovarian Follicle|Follicle Count|Follicle Size|Oral Contraceptive
|
January 2011
|
Phase 1
|
NCT02455453
|
Washington University School of Medicine
|
Breast Cancer
|
April 28, 2015
|
Phase 2
|
NCT03003949
|
University of North Carolina, Chapel Hill|National Institute of Mental Health (NIMH)
|
Perimenopausal Disorder|Stress, Emotional
|
January 24, 2017
|
Phase 1|Phase 2
|
NCT01710696
|
Novo Nordisk A+S
|
Genetic Disorder|Turner Syndrome
|
July 23, 1998
|
Phase 3
|
NCT00245921
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Contraception
|
February 2003
|
Phase 3
|
NCT03238092
|
Hospital de Clinicas de Porto Alegre
|
Fertility Disorders
|
August 2017
|
Phase 3
|
NCT02866786
|
S.C.B. Medical College and Hospital
|
Polycystic Ovary Syndrome
|
August 15, 2016
|
Phase 4
|
NCT00455741
|
Massachusetts General Hospital|National Institute on Aging (NIA)
|
Postmenopause|Aging
|
November 2000
|
Phase 1|Phase 2
|
NCT03755037
|
Nesreen Abdel Fattah Abdullah Shehata|Beni-Suef University
|
Female Infertility
|
January 31, 2017
|
Phase 1
|
NCT01340625
|
Teva Pharmaceuticals USA
|
Bioequivalence
|
December 2006
|
Phase 1
|
NCT01367912
|
Zekai Tahir Burak Women´s Health Research and Education Hospital
|
Infertility
|
February 2008
|
Not Applicable
|
NCT01817530
|
AbbVie
|
Heavy Uterine Bleeding|Uterine Fibroids
|
April 8, 2013
|
Phase 2
|
NCT01762943
|
University of North Carolina, Chapel Hill|Foundation of Hope, North Carolina|North Carolina Translational and Clinical Sciences Institute|National Institutes of Health (NIH)|National Alliance for Research on Schizophrenia and Depression|National Institute of Mental Health (NIMH)
|
Postpartum Depression
|
August 2013
|
Not Applicable
|
NCT00320580
|
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
|
Metrorrhagia
|
|
Phase 2
|
NCT02486757
|
Massachusetts General Hospital
|
Menstruation Disturbances
|
April 2015
|
Early Phase 1
|
NCT02352090
|
Helsinki University Central Hospital|Oulu University Hospital
|
Contraception
|
February 2015
|
Phase 4
|
NCT02467673
|
University Potiguar|InBios International, Inc.|Federal University of São Paulo
|
Menopausal Syndrome
|
January 2012
|
Phase 2
|
NCT03172533
|
University of Erlangen-Nürnberg Medical School
|
Anorexia Nervosa
|
March 15, 2016
|
Phase 2
|
NCT00711607
|
Merck Sharp & Dohme Corp.|CRS Mannheim GmbH
|
Healthy
|
May 2007
|
Phase 1
|
NCT01500863
|
IVI Madrid
|
Ovarian Hyperstimulation Syndrome
|
November 2011
|
Phase 4
|
NCT02122198
|
University of Colorado, Denver
|
Cognitive Impairment|Executive Dysfunction|Endothelial Dysfunction|Cardiovascular Disease
|
September 8, 2014
|
Not Applicable
|
NCT02316249
|
Northwell Health
|
Atrophy of Vagina|Vaginal Ulceration|Vaginitis
|
April 2015
|
Phase 2
|
NCT02757469
|
Navy General Hospital, Beijing
|
Primary Ovarian Insufficiency|Menopause, Premature
|
May 2016
|
Not Applicable
|
NCT01308814
|
University of North Carolina, Chapel Hill|National Institute of Mental Health (NIMH)
|
Perimenopause|Menopause|Depression
|
October 2010
|
Phase 2|Phase 3
|
NCT00254865
|
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
|
Contraception|Female Contraception
|
August 2002
|
Phase 1
|
NCT00003771
|
Regional Oncologic Center|Scandinavian Breast Group|International Breast Cancer Study Group|European Organisation for Research and Treatment of Cancer - EORTC|National Cancer Institute (NCI)
|
Breast Cancer|Menopausal Symptoms
|
September 1997
|
Phase 3
|
NCT00997893
|
University of Illinois at Chicago|National Institute of Mental Health (NIMH)
|
Menopause|Hot Flashes
|
December 2009
|
Phase 2
|
NCT01958073
|
University of California, San Diego|American Urogynecologic Society|New York University School of Medicine
|
Recurrent Urinary Tract Infection
|
October 2013
|
Phase 4
|
NCT02984696
|
Catholic University of the Sacred Heart
|
Hypothalamic Amenorrhea
|
March 2015
|
Not Applicable
|
NCT02251925
|
Royan Institute
|
Infertility
|
September 2012
|
Phase 3
|
NCT00442689
|
Northwestern University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
Polycystic Ovary Syndrome|Metabolic Syndrome
|
July 2006
|
Not Applicable
|
NCT01381016
|
University of Colorado, Denver
|
Obesity|Infertility
|
June 2011
|
Not Applicable
|
NCT01596010
|
Novo Nordisk A+S
|
Menopause|Healthy
|
October 2007
|
Phase 1
|
NCT03681691
|
Wake Forest University Health Sciences|National Institute on Aging (NIA)
|
Diabetes Type 2|Dementia
|
January 2019
|
Phase 1
|
NCT02577601
|
Oregon Health and Science University|Society of Family Planning
|
Contraception
|
September 8, 2015
|
Phase 4
|
NCT00391807
|
Warner Chilcott
|
Contraception
|
November 2006
|
Phase 3
|
NCT01477632
|
Novo Nordisk A+S
|
Menopause|Healthy
|
March 2005
|
Phase 1
|
NCT00160316
|
Solvay Pharmaceuticals
|
Postmenopause
|
April 2005
|
Phase 3
|
NCT00254189
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Ovulation
|
December 2002
|
Phase 2
|
NCT03401047
|
University of Virginia
|
Polycystic Ovary Syndrome
|
November 30, 2017
|
Early Phase 1
|
NCT03359057
|
Galeno Desenvolvimento de Pesquisas Clínicas|Biolab Sanus Farmaceutica
|
Contraception
|
February 26, 2013
|
Phase 3
|
NCT03395665
|
Institut Universitari Dexeus
|
Infertility|Preimplantation Genetic Diagnosis+Screening|Miscarriage
|
January 2014
|
|
NCT01251263
|
Scott and White Hospital & Clinic
|
Menstrual Migraines|Menstrual Bleeding|Menstrual Spotting
|
October 2010
|
Phase 4
|
NCT00128934
|
Wyeth is now a wholly owned subsidiary of Pfizer
|
Menstruation Disturbances|Premenstrual Syndrome
|
August 2005
|
Phase 3
|
NCT03547024
|
Janssen-Cilag International NV
|
Healthy
|
June 8, 2018
|
Phase 1
|
NCT00113100
|
University of Michigan
|
Skin Wrinkling
|
August 2004
|
Not Applicable
|
NCT00108238
|
US Department of Veterans Affairs|VA Office of Research and Development
|
Healthy
|
April 2003
|
Phase 4
|
NCT00946192
|
Massachusetts General Hospital|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Exercise-related Amenorrhea
|
May 2009
|
Phase 3
|
NCT01052623
|
Johann Wolfgang Goethe University Hospital
|
Ataxia Telangiectasia|Growth Failure
|
January 2010
|
Phase 4
|
NCT03651427
|
Hospital de Clinicas de Porto Alegre
|
Gender Dysphoria
|
February 13, 2017
|
Not Applicable
|
NCT01980680
|
Peter Humaidan|Regionshospitalet Viborg, Skive
|
Infertility
|
December 2014
|
Phase 4
|
NCT00490308
|
Assaf-Harofeh Medical Center
|
Infertility
|
August 2007
|
Phase 1
|
NCT01031355
|
Bayer
|
Contraception|Ovulation Inhibition
|
December 2009
|
Phase 1
|
NCT01441635
|
AbbVie (prior sponsor, Abbott)|AbbVie
|
Heavy Uterine Bleeding|Uterine Fibroids
|
September 2011
|
Phase 2
|
NCT02736032
|
Cairo University|Nile Ivf Center, Cairo, Egypt|Kamal Shaeer center of infertility
|
Infertility
|
March 2016
|
Phase 3
|
NCT02524561
|
Brigham and Women´s Hospital|National Cancer Institute (NCI)|Kronos Longevity Research Institute|Albert Einstein College of Medicine, Inc.|Columbia University|Mayo Clinic|University of California, San Francisco|University of Utah|University of Washington|Yale University
|
Mammographic Density|Abnormal Mammogram
|
September 2005
|
Not Applicable
|
NCT02352597
|
Cairo University
|
Polycystic Ovaries
|
January 2013
|
Phase 4
|
NCT03498313
|
University of Illinois at Chicago|National Institute of Mental Health (NIMH)
|
Suicidal Ideation
|
April 15, 2018
|
Phase 4
|
NCT00326404
|
The Hospital for Sick Children|The Physicians´ Services Incorporated Foundation
|
Contraception
|
May 2006
|
Phase 3
|
NCT00140998
|
Nemours Children´s Clinic|Eli Lilly and Company
|
Turner Syndrome|Hypogonadism|Premature Ovarian Failure
|
January 2001
|
Phase 3
|
NCT01973816
|
University Hospital, Rouen
|
Endometriosis
|
November 2014
|
Phase 3
|
NCT00213096
|
Population Council|United States Agency for International Development (USAID)
|
Contraception
|
March 2003
|
Phase 2
|
NCT01015677
|
Merck Sharp & Dohme Corp.
|
Moderate to Severe Vasomotor Symptoms in Postmenopausal|Women
|
December 17, 2009
|
Phase 2
|
NCT00258063
|
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
|
Contraception|Female Contraception
|
May 2004
|
Phase 1
|
NCT00775242
|
Centro A.F. de Estudios Tecnologicos, S.A.
|
Menopause
|
April 2007
|
Phase 2|Phase 3
|
NCT02195986
|
Mylan Inc.|Mylan Pharmaceuticals
|
Atrophic Vaginitis
|
June 2014
|
Phase 3
|
NCT00167648
|
University of Washington|Pacific Northwest SPORE (Specialized Projects in Oncology Research Excellence)
|
Cancer|Prostate Neoplasms
|
March 2005
|
Phase 2
|
NCT02995694
|
Alvogen Pine Brook LLC
|
Atrophic Vaginitis
|
April 2016
|
Phase 3
|
NCT00237042
|
University of Washington|National Institute of Dental and Craniofacial Research (NIDCR)
|
Temporomandibular Joint Disorders
|
October 2005
|
Not Applicable
|
NCT02670785
|
Warner Chilcott
|
Vulvovaginal Atrophy|Menopause|Dyspareunia
|
February 15, 2016
|
Phase 2
|